In many organisms, developmentally programmed double-strand breaks (DSBs) formed by the SPO11 transesterase initiate meiotic recombination, which promotes pairing and segregation of homologous chromosomes 1 . Because every chromosome must receive a minimum number of DSBs, attention has focused on factors that support DSB formation 2 . However, improperly repaired DSBs can cause meiotic arrest or mutation 3,4 ; thus, having too many DSBs is probably as deleterious as having too few. Only a small fraction of SPO11 protein ever makes a DSB in yeast or mouse 5 and SPO11 and its accessory factors remain abundant long after most DSB formation ceases 1 , implying the existence of mechanisms that restrain SPO11 activity to limit DSB numbers. Here we report that the number of meiotic DSBs in mouse is controlled by ATM, a kinase activated by DNA damage to trigger checkpoint signalling and promote DSB repair. Levels of SPO11-oligonucleotide complexes, by-products of meiotic DSB formation, are elevated at least tenfold in spermatocytes lacking ATM. Moreover, Atm mutation renders SPO11-oligonucleotide levels sensitive to genetic manipulations that modulate SPO11 protein levels. We propose that ATM restrains SPO11 via a negative feedback loop in which kinase activation by DSBs suppresses further DSB formation. Our findings explain previously puzzling phenotypes of Atm-null mice and provide a molecular basis for the gonadal dysgenesis observed in ataxia telangiectasia, the human syndrome caused by ATM deficiency.
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SPO11 creates DSBs via a covalent protein-DNA intermediate that is endonucleolytically cleaved to release SPO11 attached to a short oligonucleotide, freeing DSB ends for further processing and recombination 5 (Fig. 1a ). SPO11-oligonucleotide complexes are a quantitative by-product of DSB formation that can be exploited to study DSB number and distribution [5] [6] [7] ( Supplementary Fig. 1 ). We examined SPO11-oligonucleotide complexes by SPO11 immunoprecipitation and 39-end labelling of whole-testis extracts from Atm -/mutant mice, which have multiple catastrophic meiotic defects, including chromosome synapsis failure and apoptosis [8] [9] [10] [11] [12] . The Atm -/phenotype resembles that of mutants lacking DSB repair factors such as DMC1, indicating that absence of ATM causes meiotic recombination defects. Although Spo11 -/mutation is epistatic to Atm -/- (refs 11, 12) , the functional relationship between ATM and SPO11 is complex, as meiotic defects of Atm -/mice are substantially rescued by reducing Spo11 gene dosage 13, 14 (discussed later).
Unexpectedly, we found that adult Atm -/testes exhibited an approximately tenfold elevation in steady-state levels of SPO11oligonucleotide complexes relative to wild-type littermates ( Fig. 1b ) (11.3 6 4.5-fold, mean and standard deviation, n 5 7 littermate pairs). This finding contrasts with Dmc1 -/testes, which showed a ,50% reduction in SPO11-oligonucleotide complexes (0.51 6 0.06-fold relative to wild type, n 5 5) ( Fig. 1c ), as previously shown 5, 7 . The mutants share similar arrest points in prophase I, as determined by molecular and histological data 12 ; thus, increased SPO11-oligonucleotide complexes in Atm -/spermatocytes are not an indirect consequence of arrest or of an increased fraction of meiocytes harbouring such complexes.
In Atm -/testes, levels of free SPO11 (that is, not bound to an oligonucleotide) were much lower than in wild type ( Fig. 1b ). This is not because a large fraction of SPO11 has been consumed in covalent complexes with DNA-which alters its electrophoretic mobility-as free SPO11 was not restored to wild-type levels by nuclease treatment (Fig. 1d ). Instead, because Spo11 transcript levels in wild type are highest in later stages of meiotic prophase [15] [16] [17] [18] , after the arrest point of Atm -/cells, reduced free SPO11 is attributable to the lack of later meiotic cell types, consistent with the reduced free SPO11 also found in -37
Anti-mSPO11: Benzonase: Dmc1 -/cells ( Fig. 1c ). As expected, the residual SPO11 protein in Atm -/-, like Dmc1 -/-, testes was mostly SPO11b (Fig. 1b, c ). SPO11a and SPO11b are major protein isoforms encoded by developmentally regulated splice variants; SPO11b is expressed earlier and is sufficient for nearly normal DSB levels 5, 15, [17] [18] [19] [20] . Elevated SPO11-oligonucleotide complexes can be explained by an increased number of meiotic DSBs and/or a longer lifespan of complexes. To distinguish between these possibilities, we examined the initial appearance and persistence of SPO11-oligonucleotide complexes in juvenile mice, in which the first suite of spermatogenic cells proceeds through meiosis in a semi-synchronous fashion 21 . First, we assayed SPO11-oligonucleotide complexes in whole-testis extracts from wild-type C57BL/6J mice at postnatal days (d)7 to 24 ( Fig. 2a ). SPO11-oligonucleotide complexes first appeared between d9 and d10, when most cells of the initial cohort had entered leptonema. SPO11oligonucleotide complexes persisted or increased slightly until d15, when the first cohort had progressed into pachynema. Levels rose still further from d16 to d18, coincident with the second cohort of spermatogenic cells reaching leptonema 21 . Thus, SPO11-oligonucleotide complexes appear at the same time as cell types that experience the majority of meiotic DSBs. Consistent with findings in mutants (see earlier), only trace amounts of free SPO11 protein were seen when SPO11-oligonucleotide complexes first appeared, with SPO11b the predominant isoform at these times ( Fig. 2a ). Importantly, SPO11oligonucleotide complex levels did not decline between the first and second spermatogenic cohorts. We infer that the lifespan of the complexes is long relative to the duration of prophase, and that an increased lifespan is not a likely explanation for the large increase in steady-state SPO11-oligonucleotides in adult Atm -/testes.
In support of this interpretation, we found that SPO11-oligonucleotide complexes were undetectable in Atm -/testes at d7 (data not shown) but were already elevated 3.3-fold compared with a wild-type littermate when they first appeared, increasing to 8.4-fold over wild type by d12 ( Fig. 2b) . Because Atm -/juveniles showed higher SPO11oligonucleotide levels as soon as the first leptotene cells appeared, we conclude that most, if not all, of the increase reflects a greater number of meiotic DSBs occurring during prophase I.
Meiotic defects of mice lacking ATM are substantially suppressed by reducing Spo11 gene dosage: Spo11 1/-Atm -/spermatocytes pair and recombine their autosomes and progress through meiotic prophase to metaphase I, where they arrest due to a failure in sex chromosome pairing and recombination 13, 14 . The reason for this puzzling rescue was unknown, but our current findings suggest an explanation: the majority of meiotic defects in Atm-null spermatocytes are caused by grossly elevated DSB levels, which are lowered by Spo11 heterozygosity (which reduces SPO11 protein levels by half in adult and juvenile testes (ref. 17 and our unpublished data)). Indeed, we found SPO11-oligonucleotide complexes in Spo11 1/-Atm -/mice to be substantially reduced compared with Atm -/littermates (Fig. 3a) . The remaining increase in SPO11-oligonucleotide complexes in Spo11 1/-Atm -/mutants compared with wild type (range of 4.5-to 7.8-fold, n 5 2) is not simply a consequence of metaphase arrest, because SPO11-oligonucleotide complexes were not elevated in mice that exhibit a similar arrest point due to absence of MLH1, a protein involved late in recombination 22 (Fig. 3a) . The fact that DSBs are still elevated in Spo11 1/-Atm -/spermatocytes relative to wild type may account for some or all of the remaining defects in this mutant, including axis interruptions at sites of ongoing recombination and persistent unrepaired DSBs late in prophase I (ref. 14) .
Our findings indicate that the absence of ATM renders the extent of DSB formation sensitive to SPO11 expression levels. Therefore, we reasoned that increasing SPO11 expression should further elevate DSB formation in ATM-deficient cells. To test this prediction, we used a previously described transgene (Xmr-Spo11b B ) that expresses the SPO11b isoform 18 . Indeed, there was substantial further elevation of SPO11-oligonucleotide complex levels (20.9 6 1.5-fold over wild-type littermates, n 5 3) upon introduction of this transgene in an Atm-null background with intact endogenous Spo11 (Fig. 3b) . By contrast, the transgene resulted in only a modest increase in SPO11-oligonucleotide complexes in an ATM-proficient background (1.1 6 0.05-fold, n 5 3) ( Fig. 3b ).
SPO11-oligonucleotide complexes from Atm-null testes were consistently shifted to a higher electrophoretic mobility compared to wild type or other mutants (Figs 1, 2b and 3) . To examine the distribution of levels in Atm-deficient spermatocytes. a, SPO11-oligonucleotide complexes are reduced in Spo11 1/-Atm -/testes relative to Atm -/-, but are more abundant than in wild type or in an Mlh1 -/mutant, which similarly arrests at metaphase. Consistent with further meiotic progression than Atm -/-, both SPO11 isoforms (a and b) are expressed in Spo11 1/-Atm -/testes, although at reduced levels due to Spo11 heterozygosity. Dagger, lower-mobility polypeptides probably originating from the Spo11 knockout allele 18 . b, SPO11-oligonucleotide complexes are further elevated by SPO11b expression from the Xmr-Spo11b B transgene (Tg Spo11b) 18 in Atm -/spermatocytes. Introducing this transgene into an otherwise wild-type background only modestly increased SPO11oligonucleotide complex levels.
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oligonucleotide lengths, labelled complexes were protease-digested and the resulting oligonucleotides were electrophoresed on a highresolution gel (Fig. 4a ). As previously shown 5 , SPO11-oligonucleotides from wild type have a bimodal length distribution with prominent subpopulations at apparent sizes of ,15-27 and ,31-35 nucleotides. Atm -/mice showed a different pattern with or without the Spo11 transgene: oligonucleotides in the shorter size range were less abundant relative to the ,31-35 nucleotide class and longer oligonucleotides appeared, including an abundant class of ,40-70 nucleotides and a subpopulation that ranged to .300 nucleotides. Spo11 1/-Atm -/mice showed an intermediate pattern, with more pronounced enrichment of the ,31-35 nucleotide class relative to both smaller and longer oligonucleotides. These results indicate that ATM influences an early step in nucleolytic processing of meiotic DSBs, as has been proposed in yeast 23 . In principle, altered oligonucleotide sizes could reflect changes in preferred positions of the endonucleolytic cleavage that releases the SPO11-oligonucleotide complex, effects on 39R59 exonucleolytic digestion of SPO11-oligonucleotides after they are formed, or occurrence of SPO11-induced DSBs at adjacent positions on the same DNA duplex (M. Neale, personal communication). Resection defects and adjacent DSBs (which conventional cytology would be unable to resolve) are both possible explanations for why SPO11-oligonucleotide complexes in Atm -/spermatocytes show a greater increase than RAD51 focus numbers 14 .
Our results reveal an essential but previously unsuspected function for ATM in controlling the number of SPO11-generated DSBs. We suggest that activation of ATM by DSBs triggers a negative feedback loop that leads to inhibition of further DSB formation (Fig. 4b ) via phosphorylation of SPO11 or its accessory proteins, several of which are known to be phosphorylated in budding yeast (for example, ref. 24) and are conserved in mammals 2 . ATM is activated in the vicinity of DSBs, as judged by SPO11-and ATM-dependent appearance of cH2AX (phosphorylated histone variant H2AX) on chromosomes at leptonema 12, 13, 25 . Thus, we envision that the negative feedback loop operates at least in part at a local level, perhaps discouraging additional DSBs from forming close to where a DSB has already formed. Such a mechanism could minimize instances where both sister chromatids are cut in the same region, and could also promote more even spacing of DSBs along chromosomes. These studies provide a new molecular framework for understanding the gonadal phenotypes of patients with ataxia telangiectasia 26 , which is caused by ATM deficiency 27 .
METHODS SUMMARY
Mouse mutant alleles and the Spo11b transgene were previously described 10, 18, [28] [29] [30] . Experimental animals were compared with controls from the same litter. Experiments conformed to regulatory standards and were approved by the MSKCC Institutional Animal Care and Use Committee. For measurement of SPO11-oligonucleotide complexes, both testes from each mouse were used per experiment, that is, littermate comparisons were made on a per-testis basis ( Supplementary Fig. 1 ). Testis extract preparation, immunoprecipitation and western blot analysis were performed essentially as described 7 . Radiolabelled species were quantified with Fuji phosphor screens and ImageGuage software. The anti-mouse SPO11 monoclonal antibody was produced from hybridoma cell line 180 (M.P.T., unpublished data). The size distribution of SPO11-oligonucleotides was determined essentially as described 5 after radiolabelling with [a-32 P] cordycepin. Benzonase treatment of SPO11-oligonucleotide complexes followed manufacturer's instructions (Novagen). LETTER RESEARCH
